Healthcare & Life Sciences

Nanomedicine Market

The nanomedicine market was valued at US$ 289.1 million in 2024 and is expected to register a CAGR of 11.4% over ....

The cerebral oximetry monitoring market was valued at US$ 244.8 million in 2024 and is expected to register a CAG....

The digestive health products market was valued at US$ 53.8 Bn in 2024 and is expected to register a CAGR of 7.5%....

The bardet-biedl syndrome diagnostics market is expected to register a CAGR of 5.8% during the forecast period of....

The laboratory diagnostic market was valued at US$ 73.1 Bn in 2024 and is expected to register a CAGR of 7.3%....

The pet ID microchip implants market was valued at US$ 167.4 million in 2024 and is expected to register a CAGR o....

The endoscope procedure kits market was valued at US$ 15.5 Billion in 2024 and is expected to register a CAGR of ....

The Car-T cell therapy market was valued at US$ 4.4 Billion in 2024 and is expected to register a CAGR of 18.1% o....

The chronic bronchitis market was valued at US$ 5.9 Billion in 2024 and is expected to register a CAGR of 5.5% ov....

The hereditary genetic testing market was valued at US$ 6.2 Billion in 2024 and is expected to register a CAGR of....

The deep vein thrombosis treatment market was valued at US$ 1.0 billion in 2024 and is expected to register a CAG....

The cardiogenic shock treatment market was valued at US$ 1.1 billion in 2024 and is expected to register a CAGR o....

The giant-cell arteritis treatment market was valued at US$ 1.2 billion in 2024 and is expected to register a CAG....

The sterile injectable contract manufacturing market was valued at US$ 16.5 billion in 2024 and is expected to re....

The liquid biopsy market was valued at US$ 3.7 Billion in 2024 and is expected to register a CAGR of 7.0% over th....